QuantumSi logo
QSIQuantumSi
Trade QSI now
QuantumSi primary media

About QuantumSi

QuantumSi (NASDAQ:QSI) is focused on pioneering next-generation semiconductor chip-based proteomics. This technology-driven company aims to revolutionize how the healthcare industry understands and utilizes proteins to diagnose and treat diseases. By developing a unique platform that leverages the power of semiconductors to read proteins, QuantumSi endeavors to unlock a deeper understanding of the molecular underpinnings of health. With projects that range from improving disease detection to facilitating personalized medicine, the company's objectives are centered on enabling advancements in medical research and patient care through their innovative approach to proteomics. QuantumSi’s efforts are squarely aimed at transforming healthcare outcomes by providing critical insights that were previously unattainable, ensuring a pivotal role in the future of medicine.

What is QSI known for?

Snapshot

Public US
Ownership
2013
Year founded
159
Employees
Branford, United States
Head office
1 of 1
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
United States

Products and/or services of QuantumSi

  • Protein sequencing platform: Revolutionizes proteomics by enabling real-time protein sequencing.
  • End-to-end solutions: Offers comprehensive services from sample preparation to data analysis.
  • Single-molecule detection: Advanced technology for detecting and analyzing individual protein molecules.
  • Compact sequencer devices: Designs portable sequencing devices for wider accessibility.
  • Software suite: Provides robust data analysis and management software for sequencing results.
  • Custom assay development: Works with researchers to develop bespoke assays tailored to specific research needs.

QuantumSi executive team

  • Mr. Jeffrey Alan HawkinsPresident, CEO & Director
  • Dr. Jonathan M. Rothberg Ph.D.Founder & Executive Director
  • Mr. Jeffry R. Keyes CPACFO & Treasurer
  • Mr. Todd C. BennettChief Commercial Officer
  • Mr. Todd RearickChief Technology Officer
  • Dr. Christian Lapointe J.D., Ph.D.General Counsel & Corporate Secretary
  • Ms. Lindsay ThompsonChief Human Resources Officer
  • Ms. Katherine AtkinsonSenior Vice President of Demand Generation & Corporate Brand
  • Dr. John S. Vieceli Ph.D.Chief Product Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.